Last reviewed · How we verify
NCT05298488
The Effect of Working at Home to Reduce Risk of Respiratory Infection
NA trial testing Home office in Respiratory Tract Infections in 2,000 participants. Status unknown.
30 March 2023
Quick facts
| Lead sponsor | Norwegian Institute of Public Health |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 2,000 |
| Start date | 14 March 2022 |
| Primary completion | 30 March 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Home office
- Office
Conditions studied
- Respiratory Tract Infections — all drugs for Respiratory Tract Infections →
- COVID-19 — all drugs for COVID-19 →
Sponsor
Norwegian Institute of Public Health
Who can join
18 and older, any sex, with Respiratory Tract Infections or COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The researchers will recruit volunteers from various organisations who are willing and able to be randomised to either working from home for 4 weeks followed by working in the office for 4 weeks, or vice versa. The goal is to assess whether working from home has an impact on the risk of symptoms of respiratory infection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05298488
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Tract Infections
Currently open trials in the same condition.
- NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
- NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
- NCT06472219 — PREDICATE Trial For Respiratory Tract Infections · Phase 3 · recruiting
- NCT05914324 — Outpatient Pediatric Pulse Oximeters in Africa · NA · recruiting
- NCT06579170 — Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada · active not recruiting
Other Norwegian Institute of Public Health trials
Trials by the same sponsor.
- NCT07442318 — Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia · NA · not yet recruiting
- NCT07135115 — Targeting Lifestyle to Improve Colorectal Cancer Screening · NA · not yet recruiting
- NCT07355569 — The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway · NA · completed
- NCT06324409 — ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening · NA · completed
- NCT06374316 — Air Purifiers in Classrooms for Infection Control - a Pilot Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05298488 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Norwegian Institute of Public Health
- Last refreshed: 28 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05298488.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing